+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Vulvar Cancer Drug"

Vulvar Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Vulvar Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 70 Pages
  • Global
From
From
Vulvar Cancer - Pipeline Review, H2 2019 - Product Thumbnail Image

Vulvar Cancer - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 243 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Vulvar cancer is a type of cancer that affects the external female genitalia. Treatment for vulvar cancer typically involves surgery, radiation therapy, and chemotherapy. Oncology drugs are used to treat cancer and can be divided into two categories: targeted therapies and immunotherapies. Targeted therapies are designed to target specific molecules or pathways involved in cancer growth and progression, while immunotherapies are designed to stimulate the body’s own immune system to fight cancer. The vulvar cancer drug market is a subset of the larger oncology drug market. It includes drugs used to treat vulvar cancer, such as chemotherapy drugs, targeted therapies, and immunotherapies. These drugs are used to treat both early and advanced stages of vulvar cancer. Some companies in the vulvar cancer drug market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, and Pfizer. Show Less Read more